<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Visikol HISTO-M | Visikol</title>
	<atom:link href="https://visikol.com/blog/tag/visikol-histo-m/feed/" rel="self" type="application/rss+xml" />
	<link>https://visikol.com</link>
	<description>Advanced Drug Discovery and Bioimaging Services</description>
	<lastBuildDate>Wed, 04 Jan 2023 16:16:51 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.5</generator>
	<item>
		<title>Researchers use Visikol HISTO-M to Study Lung Adenocarcinoma</title>
		<link>https://visikol.com/blog/2023/01/04/researchers-use-visikol-histo-m-to-study-lung-adenocarcinoma/</link>
		
		<dc:creator><![CDATA[Carol Tomaszewski]]></dc:creator>
		<pubDate>Wed, 04 Jan 2023 16:16:51 +0000</pubDate>
				<category><![CDATA[Blogs]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[Latest Blogs]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Lung]]></category>
		<category><![CDATA[lung cancer]]></category>
		<category><![CDATA[Visikol HISTO-M]]></category>
		<guid isPermaLink="false">https://visikol.com/?p=18907</guid>

					<description><![CDATA[Heatmap of lung cancer tissue section depicting number of CD3+ cells as a function of distance into the tumor.   In the United States lung cancer accounts for approximately 140,000 deaths annually and is the third most common cancer. Lung cancer is divided into two main types; small cell lung cancer and the  [...]]]></description>
										<content:encoded><![CDATA[<div class="fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container nonhundred-percent-fullwidth non-hundred-percent-height-scrolling" style="--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;" ><div class="fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-content-wrap" style="max-width:1216.8px;margin-left: calc(-4% / 2 );margin-right: calc(-4% / 2 );"><div class="fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_3 1_3 fusion-flex-column" style="--awb-bg-size:cover;--awb-width-large:33.333333333333%;--awb-margin-top-large:0px;--awb-spacing-right-large:5.76%;--awb-margin-bottom-large:0px;--awb-spacing-left-large:5.76%;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:1.92%;--awb-spacing-left-medium:1.92%;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;"><div class="fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column"><div class="fusion-image-element " style="--awb-caption-title-font-family:var(--h2_typography-font-family);--awb-caption-title-font-weight:var(--h2_typography-font-weight);--awb-caption-title-font-style:var(--h2_typography-font-style);--awb-caption-title-size:var(--h2_typography-font-size);--awb-caption-title-transform:var(--h2_typography-text-transform);--awb-caption-title-line-height:var(--h2_typography-line-height);--awb-caption-title-letter-spacing:var(--h2_typography-letter-spacing);"><span class=" fusion-imageframe imageframe-none imageframe-1 hover-type-none"><img fetchpriority="high" decoding="async" width="400" height="183" title="CD3-heatmap-overlay-scaled" src="https://visikol.com/wp-content/uploads/2023/01/CD3-heatmap-overlay-scaled-1-400x183.jpg" alt class="img-responsive wp-image-18917" srcset="https://visikol.com/wp-content/uploads/2023/01/CD3-heatmap-overlay-scaled-1-200x91.jpg 200w, https://visikol.com/wp-content/uploads/2023/01/CD3-heatmap-overlay-scaled-1-400x183.jpg 400w, https://visikol.com/wp-content/uploads/2023/01/CD3-heatmap-overlay-scaled-1-600x274.jpg 600w, https://visikol.com/wp-content/uploads/2023/01/CD3-heatmap-overlay-scaled-1-800x366.jpg 800w, https://visikol.com/wp-content/uploads/2023/01/CD3-heatmap-overlay-scaled-1-1200x549.jpg 1200w" sizes="(max-width: 1024px) 100vw, (max-width: 640px) 100vw, 400px" /></span></div><div class="fusion-text fusion-text-1" style="--awb-font-size:12px;"><p style="text-align: center;"><em>Heatmap of lung cancer tissue section depicting number of CD3+ cells as a function of distance into the tumor.</em></p>
</div></div></div><div class="fusion-layout-column fusion_builder_column fusion-builder-column-1 fusion_builder_column_2_3 2_3 fusion-flex-column" style="--awb-bg-size:cover;--awb-width-large:66.666666666667%;--awb-margin-top-large:0px;--awb-spacing-right-large:2.88%;--awb-margin-bottom-large:0px;--awb-spacing-left-large:2.88%;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:1.92%;--awb-spacing-left-medium:1.92%;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;"><div class="fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column"><div class="fusion-text fusion-text-2"><p><a href="https://gis.cdc.gov/Cancer/USCS/?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcancer%2Fdataviz%2Findex.htm#/AtAGlance/">In the United States lung cancer accounts for approximately 140,000 deaths annually and is the third most common cancer</a>. Lung cancer is divided into two main types; small cell lung cancer and the more common non-small cell lung cancer of which lung adenocarcinoma is a subtype and accounts for approximately 50% of all lung cancers. Lung adenocarcinomas (LADC) are particularly difficult to treat, likely due to their heterogenous nature. The majority of LADCs consist of multiple histological subtypes, which can include lepidic, papillary, acinar, micropapillary, and solid. Attempts to understand the formation of this histological heterogeneity indicated no direct relationship between the heterogeneity and specific genetic alterations leading researchers to explore tumor environment as a possible factor.</p>
</div></div></div><div class="fusion-layout-column fusion_builder_column fusion-builder-column-2 fusion_builder_column_1_1 1_1 fusion-flex-column" style="--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:1.92%;--awb-margin-bottom-large:0px;--awb-spacing-left-large:1.92%;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:1.92%;--awb-spacing-left-medium:1.92%;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;"><div class="fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column"><div class="fusion-text fusion-text-3"><h3>TGFβ Signaling Activated by Cancer-Associated Fibroblasts Determines the Histological Signature of Lung Adenocarcinoma</h3>
<p>In a study entitled, “<a href="https://pubmed.ncbi.nlm.nih.gov/34289987/">TGFβ Signaling Activated by Cancer-Associated Fibroblasts Determines the Histological Signature of Lung Adenocarcinoma</a>” researchers explored the influence of the tumor microenvironment on the development of histological subtypes. Both <em>in vivo </em>and <em>in vitro</em> culture of tumor cells were assessed. The <em>in vivo</em> placement of A549 tumors in immunodeficient mice showed distinctive histological features based on placement location within the mouse. To lend further credence to the idea that microenvironment plays a role in cell phenotype, solid- and acinar-typed tumors were removed and reinjected into different regions in mice where transitions from solid-to-acinar (SAT) or from acinar-to-solid (AST) were observed. The researchers then focused on the acinar-type tumors which have a stromal cell-type component, these cancer-associated fibroblasts were isolated, immortalized and used as a component of <em>in vitro</em> work to better understand the cellular mechanisms that underlie the cell subtype transitions.</p>
<p>The <em>in vitro</em> work examined three lung cancer cell lines (A459, Calu-3 and NCI-H292) and utilized the <a href="https://visikol.com/products/visikol-histo/">Visikol HISTO tissue-clearing technique</a> for immunofluorescent labeling and clearing of tumor colonies. The lung cancer cells were cultured alone or co-cultured with cancer-associated fibroblasts (CAFs) to better elucidate the role of CAFs in formation of the acinar cell subtype. All three co-culture models revealed gland-like structures compared to models with cancer cells alone indicating SAT induction in the co-culture model. Additional analysis via RNA-sequencing was performed to further delve into the molecular mechanisms behind this phenomenon. Gene expression analysis showed increased levels of genes related to the TGFβ signaling pathway. Using this information, the <em>in vitro</em> co-culture model using CAFs and A549s were treated with siRNA or inhibitors related to TGFβ signaling and both methods showed decreases in acinar formation indicating a key role of TGFβ signaling in the induction of the acinar subtype through SAT. A better understanding of tumor heterogeneity in lung adenocarcinomas is crucial to the development of effective therapeutics and diagnostic criteria and this research paves the way for a more focused approach to targeting specific LADC subtypes.</p>
<p>As a leader in <a href="https://visikol.com/services/in-vitro/">advanced cell culture</a> and <a href="https://visikol.com/services/analysis/">imaging</a>, Visikol offers products and services can be used to evaluate <a href="https://visikol.com/areas/oncology/">cancer progression and therapeutics</a>. <a href="https://visikol.com/get-started-today/">Reach out today to learn more about how Visikol can help you drive science forward</a>!</p>
</div></div></div></div></div>The post <a href="https://visikol.com/blog/2023/01/04/researchers-use-visikol-histo-m-to-study-lung-adenocarcinoma/">Researchers use Visikol HISTO-M to Study Lung Adenocarcinoma</a> first appeared on <a href="https://visikol.com">Visikol</a>.]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Researchers Use Histo-M to Study Chemical Safety in Humans</title>
		<link>https://visikol.com/blog/2022/07/14/histo-m-chemical-safety-in-humans/</link>
		
		<dc:creator><![CDATA[Carol Tomaszewski]]></dc:creator>
		<pubDate>Thu, 14 Jul 2022 12:55:10 +0000</pubDate>
				<category><![CDATA[Blogs]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[Latest Blogs]]></category>
		<category><![CDATA[3D cell culture]]></category>
		<category><![CDATA[3d Models]]></category>
		<category><![CDATA[Visikol HISTO-M]]></category>
		<guid isPermaLink="false">https://visikol.com/?p=17896</guid>

					<description><![CDATA[With the increased adoption of holistic health approaches and a stronger consciousness of how the environment impacts our health, an important application of in vitro studies arises. A growing population has become concerned with how extraneous chemicals interrupt endocrine function, and recent advances in cell culture techniques allow researchers to effectively investigate this question.  [...]]]></description>
										<content:encoded><![CDATA[<div class="fusion-fullwidth fullwidth-box fusion-builder-row-2 fusion-flex-container nonhundred-percent-fullwidth non-hundred-percent-height-scrolling" style="--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;" ><div class="fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-content-wrap" style="max-width:1216.8px;margin-left: calc(-4% / 2 );margin-right: calc(-4% / 2 );"><div class="fusion-layout-column fusion_builder_column fusion-builder-column-3 fusion_builder_column_1_1 1_1 fusion-flex-column" style="--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:1.92%;--awb-margin-bottom-large:30px;--awb-spacing-left-large:1.92%;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:1.92%;--awb-spacing-left-medium:1.92%;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;"><div class="fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column"><div class="fusion-text fusion-text-4"><p><img decoding="async" class="wp-image-17224 alignleft" src="https://visikol.com/wp-content/uploads/2022/05/High-Rez-Image-6-min-600x597.png" alt="" width="203" height="202" srcset="https://visikol.com/wp-content/uploads/2022/05/High-Rez-Image-6-min-66x66.png 66w, https://visikol.com/wp-content/uploads/2022/05/High-Rez-Image-6-min-100x100.png 100w, https://visikol.com/wp-content/uploads/2022/05/High-Rez-Image-6-min-150x150.png 150w, https://visikol.com/wp-content/uploads/2022/05/High-Rez-Image-6-min-200x199.png 200w, https://visikol.com/wp-content/uploads/2022/05/High-Rez-Image-6-min-300x298.png 300w, https://visikol.com/wp-content/uploads/2022/05/High-Rez-Image-6-min-400x398.png 400w, https://visikol.com/wp-content/uploads/2022/05/High-Rez-Image-6-min-500x497.png 500w, https://visikol.com/wp-content/uploads/2022/05/High-Rez-Image-6-min-600x597.png 600w, https://visikol.com/wp-content/uploads/2022/05/High-Rez-Image-6-min-700x696.png 700w, https://visikol.com/wp-content/uploads/2022/05/High-Rez-Image-6-min-768x764.png 768w, https://visikol.com/wp-content/uploads/2022/05/High-Rez-Image-6-min-800x796.png 800w, https://visikol.com/wp-content/uploads/2022/05/High-Rez-Image-6-min-1024x1019.png 1024w, https://visikol.com/wp-content/uploads/2022/05/High-Rez-Image-6-min-1200x1194.png 1200w, https://visikol.com/wp-content/uploads/2022/05/High-Rez-Image-6-min.png 1492w" sizes="(max-width: 203px) 100vw, 203px" />With the increased adoption of holistic health approaches and a stronger consciousness of how the environment impacts our health, an important application of <em>in vitro </em>studies arises. A growing population has become concerned with how extraneous chemicals interrupt endocrine function, and recent advances in cell culture techniques allow researchers to effectively investigate this question. Visikol is a leader in the <a href="https://visikol.com/services/in-vitro/">cell culture industry</a>, utilizing patented clearing technologies and robust 3D models to evaluate the functioning of major organ systems in both healthy and diseased states. One of the body’s most vital systems – the hypothalamic-pituitary-thyroid (HPT) axis – is of particular research interest when it comes to endocrine perturbations because it is fundamental to metabolic equilibrium, growth, and cognitive development.</p>
<p>Plant protection products (PPPs) are particularly prevalent environmental stressors, but the extent to which they interrupt thyroid hormones (TH) is a question that remains for regulatory authorities.</p>
<h3><strong>The Method</strong></h3>
<p>In a recent publication entitled, <a href="https://www.altex.org/index.php/altex/article/view/2349">“A Microfluidic Thyroid-Liver Platform to Assess Chemical Safety in Humans,”</a> researchers investigated human-relevant interferences of thyroid gland function through the HPT axis – or more specifically, TH catabolism through hepatic enzyme induction. To address the limitations of standard human <em>in-vitro </em>assays, researchers utilized human 3D thyroid and liver organoids on a micro physiological organ chip to evaluate the effects of methimazole (a reference thyroid peroxidase (TPO) inhibitor) over the course of 21 days. With the help of <a href="https://visikol.com/products/visikol-histo-m/">Visikol’s HISTO-M®</a>, samples were cleared to allow for characterization of 3D thyroid model morphology and morphological changes, cAMP accumulation, thyroid hormone secretion, and TPO inhibition. Additional characterization was performed on the liver spheroids to understand TH catabolism, glucuronidated and sulfated thyroxine (gT4/sT4) metabolite formation, and activation of nuclear receptors. Lastly, the functionality of these two 3D models together was assessed on a perfused multi-organ chip platform <img decoding="async" class="wp-image-5297 alignright" src="https://visikol.com/wp-content/uploads/2019/01/Open-Liver-HepaRG-NP-3D.png" alt="" width="194" height="194" srcset="https://visikol.com/wp-content/uploads/2019/01/Open-Liver-HepaRG-NP-3D-66x66.png 66w, https://visikol.com/wp-content/uploads/2019/01/Open-Liver-HepaRG-NP-3D-100x100.png 100w, https://visikol.com/wp-content/uploads/2019/01/Open-Liver-HepaRG-NP-3D-150x150.png 150w, https://visikol.com/wp-content/uploads/2019/01/Open-Liver-HepaRG-NP-3D-200x200.png 200w, https://visikol.com/wp-content/uploads/2019/01/Open-Liver-HepaRG-NP-3D-300x300.png 300w, https://visikol.com/wp-content/uploads/2019/01/Open-Liver-HepaRG-NP-3D.png 399w" sizes="(max-width: 194px) 100vw, 194px" />(the Chip2) to simulate the <em>in vivo </em>interaction between these two organ systems.</p>
<p>Overall, 3D cell culture models allow us to assess the human relevance of safety-related findings in animal models with respect to thyroid toxicity. This research is essential to the development of new PPPs and represents scientifically informed advancement toward a safer, healthier environment. Visikol’s attention to the development of highly useful 3D models is an essential element not only to this research but also to our understanding of how complex organ systems work. <a href="https://visikol.com/get-started-today/">Please reach out to explore what Visikol can do for you</a>.</p>
</div></div></div></div></div>The post <a href="https://visikol.com/blog/2022/07/14/histo-m-chemical-safety-in-humans/">Researchers Use Histo-M to Study Chemical Safety in Humans</a> first appeared on <a href="https://visikol.com">Visikol</a>.]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Corning Adds 3D Clear Tissue Clearing Reagent to its 3D Cell Culture Imaging Portfolio</title>
		<link>https://visikol.com/blog/2020/08/06/corning-adds-3d-clear-tissue-clearing-reagent-to-its-3d-cell-culture-imaging-portfolio/</link>
		
		<dc:creator><![CDATA[Mike Johnson]]></dc:creator>
		<pubDate>Thu, 06 Aug 2020 14:12:19 +0000</pubDate>
				<category><![CDATA[Blogs]]></category>
		<category><![CDATA[3D Clear]]></category>
		<category><![CDATA[corning]]></category>
		<category><![CDATA[HCS]]></category>
		<category><![CDATA[organoid]]></category>
		<category><![CDATA[spheroid]]></category>
		<category><![CDATA[Visikol]]></category>
		<category><![CDATA[Visikol HISTO-M]]></category>
		<guid isPermaLink="false">https://visikol.com/?p=13315</guid>

					<description><![CDATA[Corning’s new tissue clearing technology is designed for in vitro 3D cell culture models such as spheroids, organoids, and microtissues. Corning Incorporated (NYSE: GLW) announced the launch of its 3D Clear Tissue Clearing Reagent, allowing for rapid and easy imaging of tissues in 3D cell culture without damaging the underlying cellular morphology. This solution,  [...]]]></description>
										<content:encoded><![CDATA[<div class="fusion-fullwidth fullwidth-box fusion-builder-row-3 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling" style="--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;" ><div class="fusion-builder-row fusion-row"><div class="fusion-layout-column fusion_builder_column fusion-builder-column-4 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last" style="--awb-bg-size:cover;"><div class="fusion-column-wrapper fusion-column-has-shadow fusion-flex-column-wrapper-legacy"><div class="fusion-text fusion-text-5"><p><em><b>Corning’s new tissue clearing technology is designed for in vitro 3D cell culture models such as spheroids, organoids, and microtissues.</b></em></p>
<p><a href="http://www.corning.com/worldwide/en.html">Corning Incorporated</a> (NYSE: GLW) announced the launch of its 3D Clear Tissue Clearing Reagent, allowing for rapid and easy imaging of tissues in 3D cell culture without damaging the underlying cellular morphology. This solution, manufactured and sold by Visikol, is now commercially available through Corning and adds to the company’s 3D cell culture portfolio. The reagent supports the generation of 3D cell culture models and subsequent characterization in one simple workflow, allowing for advancement in drug screening and other essential areas of research.</p>
<p>The <a href="https://www.corning.com/worldwide/en/products/life-sciences/products/media-sera-reagents/3d-clear-tissue-clearing-reagent.html">3D Clear Tissue Clearing Reagent</a> was designed specifically to be compatible with 3D cell culture models and enables researchers to simply and efficiently generate and image those models. The use of tissue clearing reagents allows for 3D cell culture models to be imaged in 3D, enabling the entire population of cells to be surveyed, allowing researchers to address complex spatial questions while improving the accuracy of their assays.</p>
<p>&#8220;We developed the Visikol tissue clearing technology to enable researchers to fully characterize 3D cell culture models so that they can leverage the extensive spatial data that makes these models intrinsically more valuable than traditional 2D cell culture models,&#8221; said Visikol CEO Michael Johnson, Ph.D.</p>
<p>“At Corning, we continue to work toward breaking down the barriers to adoption for 3D cell culture models, as they have become increasingly useful in studying critical disease areas,” said Kim Titus, director of Business Operations, Corning Life Sciences. “With this new product, we aim to provide a rapid, easy-to-use process that adds a new dimension to research; making it easy for scientists to integrate 3D imaging into existing tissue processing workflows.”</p>
</div><div class="fusion-button-wrapper"><a class="fusion-button button-flat fusion-button-default-size button-default fusion-button-default button-1 fusion-button-default-span fusion-button-default-type" target="_self" href="https://www.corning.com/worldwide/en/about-us/news-events/corning-adds-3d-clear-tissue-clearing-reagent-to-its-3d-cell-culture-imaging-portfolio.html"><span class="fusion-button-text awb-button__text awb-button__text--default">Full Press Release</span></a></div><div class="fusion-clearfix"></div></div></div></div></div>The post <a href="https://visikol.com/blog/2020/08/06/corning-adds-3d-clear-tissue-clearing-reagent-to-its-3d-cell-culture-imaging-portfolio/">Corning Adds 3D Clear Tissue Clearing Reagent to its 3D Cell Culture Imaging Portfolio</a> first appeared on <a href="https://visikol.com">Visikol</a>.]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
